AEGiS-AP: Anthrax attacks, flu vaccine shortage, Medicare drug bill marked Thompson's tenure Associated PressImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu




DonateNow



Anthrax attacks, flu vaccine shortage, Medicare drug bill marked Thompson's tenure

Associated Press - December 3, 2004
Mark Sherman, Associated Press Writer


WASHINGTON (AP) - Anthrax attacks and a flu vaccine shortage troubled the first and last years of Tommy Thompson's tenure as Health and Human Services secretary. A much brighter note, he said Friday, was the Medicare prescription law he helped pass in 2003.

Thompson, 63, announced his resignation Friday, saying he was likely to pursue a job in the private sector after nearly 40 years in politics and government.

"We touched the third rail of politics and delivered on our promise to modernize Medicare with prescription drug coverage," Thompson said.

The Medicare law has been bitterly debated, both before and after its passage, with critics contending it showers money on insurers and drug makers at the expense of older Americans.

Despite that criticism, however, Thompson won praise Friday from Sen. Edward M. Kennedy, D-Mass., who said the secretary "was always willing to try to tackle issues objectively."

Thompson had been the nation's longest-serving governor when Bush named him to lead the department. He made his mark as governor by pushing for an overhaul of Wisconsin welfare laws, well before Congress and President Clinton took up the issue on the national level.

But a month after the Sept. 11 attacks, the nation faced its first case of bioterrorism in the form of anthrax attacks against government and media targets in Washington, Florida and New York.

Thompson generally escaped criticism, but lawmakers complained that the Centers for Disease Control and Prevention reacted slowly to the crisis.

This year, similar criticism has been leveled at the Food and Drug Administration for its reaction to the loss of half the U.S. supply of flu vaccine because of contamination at a manufacturing plant in England.

The FDA also has come under fire for its handling of safety concerns about Merck & Co.'s Vioxx painkiller.

Thompson, meanwhile, has been a key player in President Bush's AIDS initiative, a commitment of $15 billion over 5 years for treatment and prevention of the scourge overseas.

He traveled frequently to Africa and is chairman of the Global Fund to Fight AIDS.

Thompson has used his AIDS role to trumpet his idea of medical diplomacy, investing in health care and medical facilities around the world. "We are forging better ties with nations by our willingness to share our great health expertise," he said in his resignation letter to Bush.

On the Net: Department of Health and Human Services: www.hhs.gov


041203
AP041216


Copyright © 2004 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .